Please wait while the formulary information is being retrieved.
MIGRANOW (SUMATRIPTAN SUCCINATE/MENTHOL/CAMPHOR)
50 mg-10 %-4 % kit, gel and tablet
- Dosage information is not available
- Azilect
- bromocriptine
- Cafergot
- Cycloset
- D.h.e.45
- dihydroergotamine
- Eldepryl
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- isocarboxazid
- linezolid
- Marplan
- Matulane
- methylene blue (antidote)
- methylergonovine
- Migergot
- Migranal
- Nardil
- Parlodel
- Parnate
- phenelzine
- procarbazine
- rasagiline
- selegiline HCl
- tranylcypromine
- Zelapar
- Zyvox
Contraindicated
- Conzip
- Nucynta
- Nucynta Er
- Synapryn
- tapentadol
- tramadol
- tramadol-acetaminophen
- tramadol-glucosamine
- Ultracet
- Ultram
- Ultram Er
Severe
Moderate
- Brintellix
- Brisdelle
- Celexa
- citalopram
- Cymbalta
- desvenlafaxine
- desvenlafaxine fumarate
- desvenlafaxine succinate
- duloxetine
- Effexor Xr
- escitalopram oxalate
- Fetzima
- fluoxetine
- fluvoxamine
- Khedezla
- levomilnacipran
- Lexapro
- Luvox Cr
- milnacipran
- olanzapine-fluoxetine
- paroxetine HCl
- paroxetine mesylate
- Paxil
- Paxil Cr
- Pexeva
- Pristiq
- Prozac
- Prozac Weekly
- Sarafem
- Savella
- sertraline
- Symbyax
- venlafaxine
- Viibryd
- vilazodone
- vortioxetine
- Zoloft
- None
Contraindicated
- None
Severe
Moderate
- None
MIGRANOW (SUMATRIPTAN SUCCINATE/MENTHOL/CAMPHOR)
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
Sumatriptan
Efficacy not established over placebo for treatment of migraine. Adverse event risk similar to adults including visual loss and stroke.
- 1 Day – 18 Years
- Efficacy not established over placebo for treatment of migraine. Adverse event risk similar to adults including visual loss and stroke.
Management or Monitoring Precaution
None
Sumatriptan
- Severity Level:
2
- Additional Notes: Insufficient human data avail, consider maternal tx benefit vs pot fetal risk
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Camphor (top)
Insufficient data available; likely compatible per briggs.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; likely compatible per briggs. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Sumatriptan
Hepatic-Elderly patients are more likely to have decreased hepatic function thus decreasing drug clearance. Cardiovascular-Hypertensive effects may be more pronounced in the elderly and increase the risk for cardiovascular events in those with cardiovascular disease. A cardiovascular evaluation is recommended in those with CV risk factors, Avoid use of the drug in any patient with a cerebrovascular syndrome.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Formulary Reference Tool